What is Enlivex Ltd's earnings per share (EPS)?

Enlivex Ltd (ENLV) reported diluted earnings per share of $25.48 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Enlivex Ltd Financials

ENLV

FY2025 annual

Revenue Not reported for FY2025

Net Income $1.2B +8329.2% YoY

EPS (Diluted) $25.48 YoY not available

Free Cash Flow -$10.5M +20.0% YoY

Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Mar 25, 2026 Currency USD FYE December

This page shows Enlivex Ltd (ENLV) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial health score not available

Enlivex Ltd does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

3/6

Enlivex Ltd passes 3 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass.

Earnings Quality No Cash Backing

$0.01used

For every $1 of reported earnings, Enlivex Ltd used $0.01 of operating cash (-$10.4M OCF vs $1.2B net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.

Key Financial Metrics

Export CSV

Earnings & Revenue

EBITDA

-$14.7M

YoY+4.2%

Enlivex Ltd's EBITDA was -$14.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 4.2% from the prior year.

Net Income

$1.2B

YoY+8329.2%

Enlivex Ltd reported $1.2B in net income in fiscal year 2025. This represents an increase of 8329.2% from the prior year.

EPS (Diluted)

$25.48

Enlivex Ltd earned $25.48 per diluted share (EPS) in fiscal year 2025.

Revenue

Not reported for fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow

-$10.5M

YoY+20.0%

Enlivex Ltd recorded an outflow of $10.5M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents an increase of 20.0% from the prior year.

Cash & Debt

$1.9M

YoY-42.6%

5Y CAGR-19.7%

Enlivex Ltd held $1.9M in cash as of fiscal year 2025; long-term debt is not reported for that period.

Shares Outstanding

237M

Enlivex Ltd had 237M shares outstanding in fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Return on Equity

63.8%

YoY+127.5pp

5Y CAGR+97.2pp

10Y CAGR+149.5pp

Enlivex Ltd's ROE was 63.8% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 127.5 percentage points from the prior year.

Gross Margin

Not reported for fiscal year 2025.

Operating Margin

Not reported for fiscal year 2025.

Net Margin

Not reported for fiscal year 2025.

Capital Allocation

R&D Spending

$9.2M

YoY-13.4%

5Y CAGR+8.6%

10Y CAGR+1.8%

Enlivex Ltd invested $9.2M in research and development in fiscal year 2025. This represents a decrease of 13.4% from the prior year.

Capital Expenditures

$68K

YoY-34.0%

5Y CAGR-41.8%

10Y CAGR+3.5%

Enlivex Ltd invested $68K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 34.0% from the prior year.

Share Buybacks

Not reported for fiscal year 2025.

ENLV Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

ENLV quarterly income statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
R&D Expenses	$9.2M-13.4%	$10.6M-44.1%	$19.0M+1.7%	$18.7M+45.1%	$12.9M+111.6%	$6.1M+8.6%	$5.6M+39.6%	$4.0M+137.3%	$1.7M-81.0%	$8.9M+15.4%	$7.7M+73.2%	$4.4M+506.7%	$732K+422.9%	$140K
SG&A Expenses	$5.8M+18.0%	$4.9M-20.0%	$6.1M-13.6%	$7.1M+10.9%	$6.4M+73.2%	$3.7M+22.7%	$3.0M+134.4%	$1.3M+167.9%	$480K-91.9%	$5.9M-15.1%	$7.0M+163.5%	$2.6M+534.4%	$416K+383.7%	$86K
Operating Income	-$15.0M+5.4%	-$15.9M+45.9%	-$29.4M-13.9%	-$25.8M-33.7%	-$19.3M-97.1%	-$9.8M-13.5%	-$8.6M-62.7%	-$5.3M-144.1%	-$2.2M+86.3%	-$15.9M-2.5%	-$15.5M-118.6%	-$7.1M-516.7%	-$1.1M-408.0%	-$226K
Income Tax	$382.6M	N/A	N/A	N/A	N/A	N/A	N/A	-$4K-114.3%	$28K-87.0%	$216K+800.0%	$24K	$0	$0	N/A
Net Income	$1.2B+8329.2%	-$15.0M+48.3%	-$29.1M+6.4%	-$31.1M-114.7%	-$14.5M-22.4%	-$11.8M-26.0%	-$9.4M-121.2%	-$4.2M-69.4%	-$2.5M+84.4%	-$16.0M-4.3%	-$15.4M-118.8%	-$7.0M-513.3%	-$1.1M-400.0%	-$229K
EPS (Diluted)	$25.48	-$0.73+53.2%	-$1.56+7.7%	-$1.69-108.6%	-$0.81+10.0%	-$0.90	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q2'25	Q1'25	Q4'24	Q2'24	Q1'24	Q4'23	Q2'23
R&D Expenses	N/A	$2.1M	N/A	N/A	$2.0M	N/A	N/A	$5.0M
SG&A Expenses	N/A	$937K	N/A	N/A	$987K	N/A	N/A	$1.6M
Operating Income	N/A	-$3.1M	N/A	N/A	-$3.0M	N/A	N/A	-$6.6M
Net Income	N/A	-$1.9M+45.9%	-$3.5M	N/A	-$3.1M+25.2%	-$4.1M	N/A	-$6.8M
EPS (Diluted)	N/A	-$0.08	N/A	N/A	-$0.16	N/A	N/A	-$0.37

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, Interest Expense, Income Tax.

ENLV Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

ENLV quarterly balance sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Total Assets	$2.3B+8304.7%	$27.7M-24.8%	$36.8M-45.6%	$67.6M-28.9%	$95.1M+135.8%	$40.4M+129.8%	$17.6M+59.1%	$11.0M+204.6%	$3.6M-65.9%	$10.6M-48.2%	$20.5M-37.7%	$33.0M+10669.3%	$306K	N/A
Current Assets	$1.7B+6606.3%	$26.0M-23.0%	$33.8M-35.5%	$52.3M-39.5%	$86.4M+126.8%	$38.1M+132.1%	$16.4M+59.8%	$10.3M+183.7%	$3.6M-65.6%	$10.5M-48.3%	$20.4M-38.0%	$32.9M+10898.3%	$299K	N/A
Cash & Equivalents	$1.9M-42.6%	$3.3M+306.0%	$813K-98.4%	$49.9M+345.9%	$11.2M+97.5%	$5.7M+43.7%	$3.9M-59.4%	$9.7M	N/A	$3.0M-58.2%	$7.3M-31.2%	$10.6M+3819.6%	$270K+84.9%	$146K
Total Liabilities	$392.1M+9466.9%	$4.1M-39.3%	$6.7M-37.5%	$10.8M+6.9%	$10.1M+107.5%	$4.9M-22.4%	$6.3M+372.7%	$1.3M+127.3%	-$4.9M-162.3%	$7.8M+202.6%	$2.6M+13.3%	$2.3M+1640.5%	$131K	N/A
Current Liabilities	$9.0M+137.5%	$3.8M-37.3%	$6.1M-8.3%	$6.6M+40.0%	$4.7M+7.9%	$4.4M-26.9%	$6.0M+429.2%	$1.1M+145.7%	$460K-76.2%	$1.9M-23.2%	$2.5M+10.3%	$2.3M+1640.5%	$131K	N/A
Total Equity	$1.9B+8102.8%	$23.6M-21.6%	$30.1M-47.1%	$56.8M-33.2%	$85.0M+139.6%	$35.5M+214.5%	$11.3M+16.2%	$9.7M+14.3%	$8.5M+202.2%	$2.8M-84.3%	$17.9M-41.5%	$30.7M+17428.0%	$175K+133.3%	$75K
Retained Earnings	$1.1B+972.0%	-$127.1M-13.4%	-$112.1M-35.0%	-$83.0M-59.8%	-$52.0M-38.6%	-$37.5M-46.1%	-$25.7M-57.6%	-$16.3M+64.4%	-$45.8M-14.9%	-$39.8M-67.4%	-$23.8M-182.4%	-$8.4M-501.6%	-$1.4M	N/A

Metric	Q4'25	Q2'25	Q1'25	Q4'24	Q2'24	Q1'24	Q4'23	Q2'23
Total Assets	$2.3B+10197.4%	$22.6M	N/A	$27.7M-13.2%	$31.9M	N/A	$36.8M-30.5%	$53.0M
Current Assets	$1.7B+8074.7%	$21.3M	N/A	$26.0M-9.0%	$28.6M	N/A	$33.8M+9.7%	$30.8M
Cash & Equivalents	$1.9M+0.1%	$1.9M	N/A	$3.3M-11.9%	$3.7M	N/A	$813K-76.5%	$3.5M
Total Liabilities	$392.1M+10962.4%	$3.5M	N/A	$4.1M+22.7%	$3.3M	N/A	$6.7M-22.4%	$8.7M
Current Liabilities	$9.0M+171.1%	$3.3M	N/A	$3.8M+33.7%	$2.8M	N/A	$6.1M+21.4%	$5.0M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$7.2M
Total Equity	$1.9B+10055.1%	$19.1M-7.6%	$20.6M-12.6%	$23.6M-17.4%	$28.6M+6.4%	$26.9M-10.7%	$30.1M-32.1%	$44.3M
Retained Earnings	$1.1B+937.0%	-$132.4M	N/A	-$127.1M-6.5%	-$119.3M	N/A	-$112.1M-15.5%	-$97.0M

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill.

ENLV Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

ENLV quarterly cash flow statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Operating Cash Flow	-$10.4M+19.9%	-$13.0M+44.7%	-$23.5M+1.8%	-$24.0M-36.5%	-$17.5M-59.4%	-$11.0M-56.3%	-$7.0M-122.7%	-$3.2M-37.2%	-$2.3M+85.1%	-$15.5M-16.9%	-$13.2M-200.5%	-$4.4M-409.7%	-$865K-480.5%	-$149K
Capital Expenditures	$68K-34.0%	$103K-56.4%	$236K-97.1%	$8.1M+399.8%	$1.6M+59.5%	$1.0M+428.0%	$193K-58.1%	$461K+254.6%	$130K+622.2%	$18K-62.5%	$48K-23.8%	$63K+3050.0%	$2K	$0
Free Cash Flow	-$10.5M+20.0%	-$13.1M+44.8%	-$23.8M+25.9%	-$32.1M-67.3%	-$19.2M-59.4%	-$12.0M-66.2%	-$7.2M-99.7%	-$3.6M-48.8%	-$2.4M+84.3%	-$15.5M-16.6%	-$13.3M-197.3%	-$4.5M-415.8%	-$867K-481.9%	-$149K
Investing Cash Flow	-$1.3M-114.6%	$9.1M+134.9%	-$26.0M-141.5%	$62.5M+262.8%	-$38.4M-83.1%	-$21.0M-229.9%	-$6.4M-1169.3%	-$501K-285.4%	-$130K-101.4%	$9.0M-9.7%	$10.0M	N/A	N/A	N/A
Financing Cash Flow	$10.4M+60.8%	$6.5M+1692.8%	$360K+140.0%	$150K-99.8%	$61.0M+84.3%	$33.1M+298.3%	$8.3M+59.9%	$5.2M-35.5%	$8.1M+32.3%	$6.1M	$0	N/A	N/A	N/A

Metric	Q4'25	Q2'25	Q1'25	Q4'24	Q2'24	Q1'24	Q4'23	Q2'23

Not reported in any period shown, so not listed: Operating Cash Flow, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.

ENLV Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

ENLV quarterly financial ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Return on Equity	63.8%+127.5pp	-63.6%+33.0pp	-96.6%-42.0pp	-54.6%-37.6pp	-17.0%+16.3pp	-33.3%+49.9pp	-83.2%-39.5pp	-43.7%-14.2pp	-29.5%+540.7pp	-570.2%-484.5pp	-85.7%-62.8pp	-22.9%+631.4pp	-654.3%-349.0pp	-305.3%
Return on Assets	53.1%+107.3pp	-54.2%+24.7pp	-78.9%-33.0pp	-45.9%-30.7pp	-15.2%+14.1pp	-29.3%+24.1pp	-53.4%-15.0pp	-38.4%+30.7pp	-69.1%+81.6pp	-150.7%-75.8pp	-74.9%-53.6pp	-21.3%+352.9pp	-374.2%	N/A
Current Ratio	193.24+186.4x	6.84+1.3x	5.57-2.3x	7.92-10.4x	18.32+9.6x	8.72+6.0x	2.75-6.3x	9.09+1.2x	7.87+2.4x	5.46-2.7x	8.11-6.3x	14.42+12.1x	2.28	N/A
Debt-to-Equity	0.200.0x	0.17-0.1x	0.220.0x	0.19+0.1x	0.120.0x	0.14-0.4x	0.56+0.4x	0.14	N/A	2.78+2.6x	0.14+0.1x	0.07-0.7x	0.75	N/A

Metric	Q4'25	Q2'25	Q1'25	Q4'24	Q2'24	Q1'24	Q4'23	Q2'23
Return on Equity	N/A	-9.8%+6.9pp	-16.7%	N/A	-10.8%+4.6pp	-15.4%	N/A	-15.3%
Return on Assets	N/A	-8.3%	N/A	N/A	-9.7%	N/A	N/A	-12.8%
Current Ratio	193.24+186.8x	6.41	N/A	6.84-3.2x	10.06	N/A	5.57-0.6x	6.17
Debt-to-Equity	0.200.0x	0.19	N/A	0.17+0.1x	0.12	N/A	0.22+0.1x	0.16

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, FCF Margin.

Similar Companies

Akari Therapeutics Plc AKTX

$17.7M

SeaStar Medical Holding Corp ICU

$13.7M

Tenax Therapeutics Inc TENX

$79.3M

Rein Therapeutics, Inc. RNTX

$69.0M

Q32 BIO INC QTTB

$481.7M

Where Enlivex Ltd Ranks

Frequently Asked Questions

Is Enlivex Ltd profitable?

Yes, Enlivex Ltd (ENLV) reported a net income of $1.2B in fiscal year 2025.

What is Enlivex Ltd's EBITDA?

Enlivex Ltd (ENLV) had EBITDA of -$14.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Enlivex Ltd's return on equity (ROE)?

Enlivex Ltd (ENLV) has a return on equity of 63.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Enlivex Ltd's free cash flow?

Enlivex Ltd (ENLV) recorded an outflow of $10.5M in free cash flow during fiscal year 2025. This represents a 20.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Enlivex Ltd's operating cash flow?

Enlivex Ltd (ENLV) recorded an outflow of $10.4M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are Enlivex Ltd's total assets?

Enlivex Ltd (ENLV) had $2.3B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Enlivex Ltd's capital expenditures?

Enlivex Ltd (ENLV) invested $68K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Enlivex Ltd spend on research and development?

Enlivex Ltd (ENLV) invested $9.2M in research and development during fiscal year 2025.

How many shares does Enlivex Ltd have outstanding?

Enlivex Ltd (ENLV) had 237M shares outstanding as of fiscal year 2025.

What is Enlivex Ltd's current ratio?

Enlivex Ltd (ENLV) had a current ratio of 193.24 as of fiscal year 2025, which is generally considered healthy.

What is Enlivex Ltd's debt-to-equity ratio?

Enlivex Ltd (ENLV) had a debt-to-equity ratio of 0.20 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Enlivex Ltd's return on assets (ROA)?

Enlivex Ltd (ENLV) had a return on assets of 53.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

How does Enlivex Ltd's liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, Enlivex Ltd (ENLV) held $5.8M in cash, cash equivalents and investments, and reported an operating cash outflow of $10.4M over that year. Dividing the one by the other, the reported balance equals about 7 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is Enlivex Ltd's Piotroski F-Score?

Enlivex Ltd (ENLV) has a Piotroski F-Score of 3 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Enlivex Ltd's earnings high quality?

For every $1 of reported earnings, Enlivex Ltd (ENLV) used $0.01 of operating cash (-$10.4M OCF vs $1.2B net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.